These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25635121)

  • 1. Mucosal and Cellular Immune Responses to Norwalk Virus.
    Ramani S; Neill FH; Opekun AR; Gilger MA; Graham DY; Estes MK; Atmar RL
    J Infect Dis; 2015 Aug; 212(3):397-405. PubMed ID: 25635121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers.
    Griffin SM; Converse RR; Leon JS; Wade TJ; Jiang X; Moe CL; Egorov AI
    J Immunol Methods; 2015 Sep; 424():53-63. PubMed ID: 25985985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen.
    Moe CL; Sair A; Lindesmith L; Estes MK; Jaykus LA
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1028-34. PubMed ID: 15539501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immunity following Snow Mountain virus challenge.
    Lindesmith L; Moe C; Lependu J; Frelinger JA; Treanor J; Baric RS
    J Virol; 2005 Mar; 79(5):2900-9. PubMed ID: 15709009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody prevalence and immunoglobulin IgG subclass pattern to Norwalk virus in Sweden.
    Hinkula J; Ball JM; Löfgren S; Estes MK; Svensson L
    J Med Virol; 1995 Sep; 47(1):52-7. PubMed ID: 8551259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral shedding and fecal IgA response after Norwalk virus infection.
    Okhuysen PC; Jiang X; Ye L; Johnson PC; Estes MK
    J Infect Dis; 1995 Mar; 171(3):566-9. PubMed ID: 7876602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.
    Sapparapu G; Czakó R; Alvarado G; Shanker S; Prasad BV; Atmar RL; Estes MK; Crowe JE
    PLoS Pathog; 2016 Jun; 12(6):e1005719. PubMed ID: 27355511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.
    Ramirez K; Wahid R; Richardson C; Bargatze RF; El-Kamary SS; Sztein MB; Pasetti MF
    Clin Immunol; 2012 Aug; 144(2):98-108. PubMed ID: 22710446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses.
    Guerrero RA; Ball JM; Krater SS; Pacheco SE; Clements JD; Estes MK
    J Virol; 2001 Oct; 75(20):9713-22. PubMed ID: 11559804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotypic humoral and cellular immune responses following Norwalk virus infection.
    Lindesmith LC; Donaldson E; Leon J; Moe CL; Frelinger JA; Johnston RE; Weber DJ; Baric RS
    J Virol; 2010 Feb; 84(4):1800-15. PubMed ID: 20007270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines.
    Hjelm BE; Kilbourne J; Herbst-Kralovetz MM
    Hum Vaccin Immunother; 2014; 10(2):410-6. PubMed ID: 24280723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of IgA responses following Norwalk virus infection and other human caliciviruses using a recombinant Norwalk virus protein EIA.
    Parker SP; Cubitt WD
    Epidemiol Infect; 1994 Aug; 113(1):143-51. PubMed ID: 8062871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiological investigation of Norwalk virus infection in South Africa.
    Taylor MB; Parker S; Grabow WO; Cubitt WD
    Epidemiol Infect; 1996 Apr; 116(2):203-6. PubMed ID: 8620912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological correlate of protection against norovirus-induced gastroenteritis.
    Reeck A; Kavanagh O; Estes MK; Opekun AR; Gilger MA; Graham DY; Atmar RL
    J Infect Dis; 2010 Oct; 202(8):1212-8. PubMed ID: 20815703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
    Mateo R; Lindesmith LC; Garg SJ; Gottlieb K; Lin K; Said S; Leon JS; Sims AC; Weber DJ; Baric RS; Tucker SN; Taylor DN
    J Infect Dis; 2020 Mar; 221(6):919-926. PubMed ID: 31628848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus GII.4 antibodies in breast milk and serum samples: their role preventing virus-like particles binding to their receptors.
    Khodayar-Pardo P; Martínez-Costa C; Carmona-Vicente N; Buesa J
    Pediatr Infect Dis J; 2014 Jun; 33(6):554-9. PubMed ID: 24830517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
    Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
    Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological Correlates of Protection against a GII.4 Norovirus.
    Atmar RL; Bernstein DI; Lyon GM; Treanor JJ; Al-Ibrahim MS; Graham DY; Vinjé J; Jiang X; Gregoricus N; Frenck RW; Moe CL; Chen WH; Ferreira J; Barrett J; Opekun AR; Estes MK; Borkowski A; Baehner F; Goodwin R; Edmonds A; Mendelman PM
    Clin Vaccine Immunol; 2015 Aug; 22(8):923-9. PubMed ID: 26041041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses against norovirus infections of children.
    Iritani N; Seto T; Hattori H; Natori K; Takeda N; Kubo H; Yamano T; Ayata M; Ogura H; Seto Y
    J Med Virol; 2007 Aug; 79(8):1187-93. PubMed ID: 17597489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.